家族性高胆固醇血症
低密度脂蛋白受体
生物
遗传学
突变
点突变
杂合子优势
基因
LRP1B型
表型
复合杂合度
受体
突变体
使负有责任或义务
等位基因
内科学
内分泌学
脂蛋白
胆固醇
医学
生态学
作者
Xi‐Ming Sun,Dilip Patel,J. L. Webb,Brian L. Knight,Le-min Fan,Haijiang Cai,Anne K. Soutar
出处
期刊:Arteriosclerosis and thrombosis
[Ovid Technologies (Wolters Kluwer)]
日期:1994-01-01
卷期号:14 (1): 85-94
被引量:110
标识
DOI:10.1161/01.atv.14.1.85
摘要
Familial hypercholesterolemia (FH), caused by many different mutations in the low-density lipoprotein (LDL)-receptor gene, invariably leads to severe premature coronary heart disease (CHD) in homozygous individuals. Heterozygous FH patients are less severely affected but are still at increased risk of CHD in most populations. Although FH homozygotes in China are affected similarly to those elsewhere, heterozygotes are not detected in the general population and obligate heterozygotes are often not hypercholesterolemic by Western standards. Mutations in the LDL-receptor genes of 10 homozygous FH patients from the Jiang-su province of China and their heterozygous parents were analyzed. These include one large and two minor deletions and eight point mutations: four are predicted to introduce a premature stop codon, five to result in a single amino acid substitution or deletion, and one to produce a protein with an abnormal cytoplasmic tail. Expression of the mutant LDL-receptor cDNAs in vitro confirmed that these mutations impaired LDL-receptor function and that several would cause a receptor-negative phenotype. Thus, the lack of clinical expression in obligate FH heterozygotes is not due to unusually "mild" mutations in the LDL-receptor gene, and other genetic or environmental factors must therefore be important in determining phenotypic expression.
科研通智能强力驱动
Strongly Powered by AbleSci AI